Phillip Minton M.D.

Archive for the ‘prostate cancer’ Category

New Immune Therapy Cancer Treatment Drug Approved

In immune system, prostate cancer on June 15, 2011 at 9:06 am

For nearly a decade now I have written intermittently on the progress of the Dendreon Corporation, as it labors to develop cancer treatment drugs that use the immune system to kill living cancer cells. The FDA recently approved their flagship drug, Provenge, as an approved treatment for prostate cancer. Keep reading…